Heart Rate Variability as a Predictor of Rebound Pain Following Total Knee Arthroplasty
Launched by KONYA CITY HOSPITAL · May 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into whether heart rate variability (HRV) can help predict rebound pain after total knee replacement surgery, which is when patients experience sudden, intense pain after their initial pain relief has worn off. By measuring HRV with a heart monitor before and after surgery, researchers hope to find out if this measurement can be used to anticipate rebound pain and improve pain management strategies for patients.
To be eligible for the study, participants should be between 18 and 70 years old and scheduled for a planned total knee replacement surgery using spinal anesthesia. They should be in good overall health, as indicated by a physical status of I-III, and be able to provide written consent and complete pain questionnaires. Participants will be asked to track their pain levels, medication use, sleep quality, and satisfaction with their care. This study is not yet recruiting, but the findings could help tailor pain management plans for future knee surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 70 years
- • American Society of Anesthesiologists (ASA) physical status I-III
- • Scheduled for elective, unilateral total knee arthroplasty under spinal anesthesia
- • Planned use of multimodal analgesia including peripheral nerve blocks
- • Ability to provide written informed consent
- • Ability to understand and complete pain diaries and questionnaires
- Exclusion Criteria:
- • Known allergy to local anesthetics
- • Contraindications to regional anesthesia
- • Contraindications to spinal anesthesia
- • ASA physical status IV or higher
- • Pregnancy or breastfeeding
- • Neurological or psychiatric disorders impairing ability to participate or report outcomes
- • Use of anticoagulant therapy or presence of coagulation disorders
- • Infection at the proposed injection site
- • Emergency (non-elective) surgical procedures
About Konya City Hospital
Konya City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on collaborative research, the hospital integrates state-of-the-art facilities and a multidisciplinary team of experienced professionals. By participating in clinical trials, Konya City Hospital aims to contribute to the development of new therapies and enhance the understanding of various medical conditions, ultimately benefiting both the local community and the broader medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Trial Officials
Mahmut Tutar, MD
Principal Investigator
KONYA CITY HOSPİTAL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported